TEVA PHARMACEUTICALS USA
- ANI Acquires Rights to Testosterone Gel 1% Pharmpro News
- Teva agrees to pay $512M in pay-for-delay case Pharmaceutical Care Management Association PCMA SmartBrief
- Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion Reuters - Markets - Deals
- Teva to buy Auspex in a $3.2 billion deal Wall Street Journal - Marketwatch - MarketPulse
- Goodwin Procter Represents Teva in Sale of Four Oncology R&D Assets to Ignyta (Goodwin Procter LLP) World News - Science
- Teva Pharmaceutical announces sale of West Rockhill facility The Perkasie News-Herald - News
- Teva Gets Warner Chilcott's Atelvia Patents Invalidated Law 360 Intellectual Property
- G&W Laboratories buying Teva plant after picking up one from Actavis Fierce Pharma Manufacturing
- Teva enters license agreement with Eagle Pharma for experimental leukemia therapy American Association of Blood Banks AABB SmartBrief
- Intellipharmaceutics Reports the Signing of an Exclusive Licensing and Manufacturing Agreement With World News - Business
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on TEVA PHARMACEUTICALS USA
- Rate TEVA PHARMACEUTICALS USA on their payment behavior
- Ask your network about TEVA PHARMACEUTICALS USA with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.